# Anti IL-18 (GSK1070806) in Behcet's Disease

> **NCT03522662** · PHASE2 · UNKNOWN · sponsor: **Cambridge University Hospitals NHS Foundation Trust** · enrollment: 12 (estimated)

## Conditions studied

- Behcet's Disease

## Interventions

- **DRUG:** GSK1070806

## Key facts

- **NCT ID:** NCT03522662
- **Lead sponsor:** Cambridge University Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03522662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03522662, "Anti IL-18 (GSK1070806) in Behcet's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03522662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*